Solutis SLT system cleared for clinical use

The U.S. Food and Drug Administration has cleared Quantel Medical’s Solutis selective laser trabeculoplasty system for clinical use, according to a news release.SLT is designed to function as a first-line or adjunct therapy to noninvasively reduce IOP in primary open-angle glaucoma patients via targeted laser energy.

Full Story →